Garsorasib shrank tumours in nearly half of patients with KRAS G12C pancreatic cancer and showed manageable side effects.
Researchers at the Cancer Center and Research Institute (CCRI) at the University of Mississippi Medical Center (UMMC) are ...
A newly identified cancer pathway may finally reveal how to stop pancreatic tumors before they spread. A Cornell-led research ...
Findings complement previously announced results in triple-negative breast cancer (TNBC) and prostate cancer models, highlighting Telomir-1’s consistent impact on cancer cell survival pathways. MIAMI, ...
Dan, diagnosed with stage 4 pancreatic cancer, shares his journey to remission and insights on clinical trials and patient ...
MIAMI, FLORIDA / ACCESS Newswire / October 14, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) (“Telomir” or the “Company”), a preclinical-stage biotechnology company developing therapies that ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback